Normal diagnostic laparoscopy
ProcedureThe appendix is left in situ e.g., not resected and no other surgical resection is needed to treat other diseases
NCT Number: NCT06917612
When appendicitis is suspected, patients are typically planned for emergency surgery preferably using a laparoscopic approach. Up to 20% of these patients will have a normal appendix, thus not suffering from appendicitis. Surgeons can either perform a normal diagnostic laparoscopy (leave the appendix in situ) or perform a negative appendectomy (resect the normal appendix). International guidelines recommend negative appendectomy based on weak evidence due to the risk of appendix cancer, but some countries and researchers advocate against negative appendectomy as these patients may experience more harm than if the appendix is left in situ. There are limited national guidelines and the decision is often left to the operating surgeon. Surgeons performing negative appendectomies argue that these prevent microappendicitis and the risk of a subsequent episode of appendicitis. As appendix cancers are rare, and a randomised controlled trial including this subgroup of patients with normal appendices undergoing emergency surgery for suspected appendicitis is unfeasible, an emulated target trial is planned.
This target trial aims to evaluate the effect of a normal diagnostic laparoscopy versus negative appendectomy during laparoscopic surgery for suspected appendicitis regarding cancer in the appendix and other complications such as death, reoperation, and readmission.
Looking for future studies?
Notify MeAll sexes
Observational
The target trial emmulates an unfeasible randomised controlled trial by using observational data to investigate the two treatment strategies (two groups) normal diagnostic laparoscopy versus negative appendectomy when a normal appendix is seen during surgery for suspected appendicitis. The assignment to the treatment strategies during surgery for suspected appendicitis is treated as randomised within the levels of the following baseline covariates; sex, age, year of index surgery, and hospital through inverse probability weighting. We will analyse data according to treatment assignment at baseline (intention-to-treat). Because the treatment strategies in this target trial are surgical, all participants will adhere to the surgical treatment strategy: neither a normal diagnostic laparoscopy nor a negative appendectomy at index surgery can be reversed. However, both may be followed by a reoperation, e.g., a new normal diagnostic laparoscopy or a laparoscopic appendectomy (for suspected appendicitis or stump appendicitis). However, this will not influence analyses but be recorded as an outcome.
As inverse probability weighting has been applied, no further adjustment in the pre-specified analyses below is needed.
The continuous outcome, delay of cancer diagnosis for the normal diagnostic laparoscopy group, will be descriptively reported as mean (SD) or median (IQR).
For dichotomous outcomes, the following analyses are planned:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The appendix is left in situ e.g., not resected and no other surgical resection is needed to treat other diseases
The appendix is resected but is without histopathological-confirmed inflammation and no other surgical resection is needed to treat other diseases
Time frame: 2 years
Histopathologically verified cancer in the appendix (primary or metastasis) in the nationwide register the Danish Pathology Data Bank e.g., SNOMED morphology codes for cancer (M8**** or M9****) in relation to the topography code of the appendix (T66000)
Time frame: 2 years
Histopathologically verified appendix cancer (primary) in the nationwide register the Danish Pathology Data Bank e.g., SNOMED morphology codes for cancer (M8**** or M9****) in relation to the topography code of the appendix (T66000)
Time frame: 2 years
Time from index normal diagnostic laparoscopy to histopathologically verified cancer in the appendix in the nationwide register Danish Pathology Data Bank, e.g., SNOMED morphology codes for cancer (M8**** or M9****) in relation to the topography code of the appendix (T66000)
Time frame: 2 years
All-cause death registered in the nationwide The Civil Registration System
Time frame: 1 year
Any reoperations registered in the nationwide Danish National Patient Register
Time frame: 1 year
Abdominal reoperations registered in the nationwide Danish National Patient Register e.g., with surgical codes KJ*** (gastrointestinal tract), KK*** (urological), or KL***(gynecological)
Time frame: 2 years
Histopathological record of an appendix in the nationwide register the Danish Pathology Data Bank e.g., record with topography code of the appendix (T66000) after index surgery, including subdivision of morphology codes into appendicitis, negative appendectomy, appendix cancer, and other
Time frame: 1 year
Any readmissions registered in the nationwide Danish National Patient Register, including subdivisions into diagnostic codes relating to different diseases
Time frame: 1 year
Subgroup analyses of all primary and secondary outcomes at the time-point 1 year after index surgery, including 100% of the included participants in the target trial
Time frame: 2 year
Subgroup analyses of all primary and secondary outcomes at the time-point 2 years after index surgery, including 75% to <100% of the included participants in the target trial
Time frame: 5 year
Subgroup analyses of all primary and secondary outcomes at the time-point 5 years after index surgery, including as few as 75% of the included participants in the target trial
Time frame: 1 year
For the secondary outcomes (death (2 years), reoperation, and readmission), confounding due to comorbidity will be explored for patients undergoing index surgery from January 1, 2010, and onwards, thus, allowing for calculating Charlson Comorbidity Index based data in the nationwide Danish National Patient Register from 5 years before to index surgery
Time frame: 2 years
For the primary outcomes, unmeasured confounding e.g., due to preoperative imaging or perioperative macroscopic suspicion of cancer, will be addressed by calculating the E value
Herlev Hospital
Other
Normal Diagnostic Laparoscopy Versus Negative Appendectomy in Patients With a Normal Appendix Undergoing Laparoscopic Surgery for Suspected Appendicitis: a Target Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07008092
Abdominal Pain, Abdominal Pain (AP)
Split, Croatia
View Trial DetailsNCT07643142
Abdominal Pain, Acute Appendicitis
Istanbul, ATASEHIR, Turkey (Türkiye)
View Trial DetailsNCT05651360
Abdominal Pain, Acute Appendicitis
Odense, Denmark
View Trial DetailsNCT07370896
Abdomen, Acute, Abdominal Pain
Villavicencio, Meta Department, Colombia
View Trial Details